Aug. 8, 2013 - NEW ROCHELLE, N.Y. -- New Rochelle, NY-The conclusions reached by the authors of a recent autopsy study stating that incretin-based drugs to treat diabetes can increase the risk of pancreatic cancer are overstated and unnecessarily alarmist, according to a Critique published in Diabetes Technology & Therapeutics , a peer-reviewed ... (more)
via New Rochelle Newswire http://www.prlog.org/12189838-unsubstantiated-claims-against-incretin-drugs-draw-fiery-response.html
via New Rochelle Newswire http://www.prlog.org/12189838-unsubstantiated-claims-against-incretin-drugs-draw-fiery-response.html
